FDA

Host cell proteins (HCPs) are process-related impurities deriving from host organisms used for the expression of biological products like recombinant proteins or viral vectors. HCPs, if not adequately controlled, can present potential risks to patient safety and compromise product quality, including stability, and have been the focus of regulatory agencies and industry for years. The [....]